Worcester biotech startup receives $1.7M NIH grant

28 Aug 2020

Economic Development

Biotechnology startup Enrich Therapeutics, based in Worcester and Groton, Conn., has received a $1.7-million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institute of Health, to work on developing its proprietary single cell isolation platform, the company announced on Aug. 17.

Click here for the full article